Piramal Pharma Limited (BOM:543635)

Piramal Pharma Revenue

Piramal Pharma had revenue of 26.17B INR in the quarter ending September 30, 2026, with 28.05% growth. This brings the company's total for the last twelve months to 97.79B, up 9.43% year-over-year. In the fiscal year ending March 31, 2026, Piramal Pharma had annual revenue of 88.69B, down -3.08%.

• Revenue (ttm): 97.79B
• Revenue Growth: +9.43%
• P/S Ratio: 3.16
• Revenue / Employee: 13.73M
• Employees: 7,120
• Market Cap: 309.45B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• outside India 75.67B 85.3%
• India 13.02B 14.7%

Fiscal year ended Mar 31, 2026 See the full Piramal Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	88.69B	-2.82B	-3.08%
Mar 31, 2025	91.51B	9.80B	11.99%
Mar 31, 2024	81.71B	10.90B	15.39%
Mar 31, 2023	70.82B	3.47B	5.16%
Mar 31, 2022	67.34B	8.47B	14.39%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error